MassChallenge Startups Create Impact

2,928

Startups Accelerated

$8.6B

Funding Raised

$3.6B

Revenue Generated

186K+

Jobs Created

Our startups

Be inspired. Search our startups.

Clear  
MobioSense

Conventional troponin tests are not sensitive enough and require multiple tests over 12 hours to detect heart attack, and are not portable for use outside of the hospital. Mobiosense has developed HERO, a portable, high sensitivity troponin test that allows hospitals to rule in/out heart attack in just 3 hours, and allows for use in ambulances to begin the diagnostic protocol at the patient's side immediately, greatly reducing ER overcrowding and directing patients to the correct path of care.
HERO detects heart attack with high-sensitivity Troponin, providing instant & affordable disease monitoring, anywhere, anytime.

Connect with MobioSense

MobioSense

2017

2017 Finalist Switzerland

2017 Finalist HealthTech

Sub industry

Diagnostics

Additional Industries
Health and Wellness
Healthcare
Healthcare Delivery
Healthcare IT

Mission

Our mission is to equip bold entrepreneurs to disrupt the status quo and to create meaningful change.